Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has actually axed its own once-monthly dual GLP-1/ GIP receptor agonist, finishing (PD...

Daiichi pays out Merck $170M to form bronchi cancer T-cell engager contract

.Merck &amp Co. has actually swiftly redeemed several of the expenses of its Harp on Rehabs purchase...

BioMarin halts preclinical genetics therapy for heart condition

.After BioMarin performed a springtime well-maintained of its pipe in April, the company has made a ...

Eisai plants molecular adhesive SEED with $1.5 B biobucks handle

.Major Pharmas stay caught to the suggestion of molecular adhesive degraders. The most recent busine...

Life science credit score firm unveils with $600M

.A new international life science debt company, called Symbiotic Funds, has actually brought up grea...

BMS trenches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing yet another big wager from the Caforio period, ending a deal...

Nuvation halts BET prevention after thinking about phase 1 data

.After looking at phase 1 record, Nuvation Bio has actually chosen to stop work with its one-time to...

' Scientific intuitiveness' led FDA experts to back Zevra's uncommon condition med

.Zevra Rehabs' unusual health condition medication seems to become on the road to authorization this...

Pfizer takes $230M hit after axing fell short DMD gene treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics treatment breakdown has actually gone a $...

AC Immune views 'landmark' potential in Alzheimer's drug records

.After much more than twenty years of work on neurodegenerative conditions, Swiss biotech air condit...